Fleury SA (FLRY3)

Currency in BRL
16.32
-0.18(-1.09%)
Closed·
Earnings results expected in 13 days
High dividend Yield
FLRY3 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
16.1816.58
52 wk Range
12.1618.10
Key Statistics
Bid/Ask
16.18 / 16.41
Prev. Close
16.32
Open
16.5
Day's Range
16.18-16.58
52 wk Range
12.16-18.1
Volume
1.41M
Average Volume (3m)
3.12M
1-Year Change
31.0564%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FLRY3 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.45
Upside
+6.95%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Fleury SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.

Employees
28000
Market
Brazil

Fleury SA Earnings Call Summary for Q4/2025

  • Fleury Q4 2025 EPS of $0.138 beat estimates by 3.06%; revenue of $2.06B exceeded forecasts by 2.49%, yet stock fell 3.38% after-hours.
  • Full-year 2025 gross revenue surpassed 9B BRL with 8.2% YoY growth; net income rose 14.7% to 96.3M BRL while EBITDA increased 12.5%.
  • B2C Diagnostic Medicine segment drove significant growth; company maintains robust operating cash flow and strong EBITDA margins.
  • FY2026 EPS guidance set at $0.24, FY2027 at $0.27; revenue projected at $1.72B and $1.82B respectively with continued digital focus.
  • CEO emphasized diversified business model strength; CFO committed to capital discipline and cash conversion amid integration and currency risks.
Last Updated: 03/26/2026, 01:30 PM
Read Full Transcript

Compare FLRY3 to Peers and Sector

Metrics to compare
FLRY3
Peers
Sector
Relationship
P/E Ratio
14.5x18.4x−0.4x
PEG Ratio
−29.230.460.00
Price/Book
1.8x1.3x2.6x
Price / LTM Sales
1.1x1.1x3.2x
Upside (Analyst Target)
9.1%23.8%46.7%
Fair Value Upside
Unlock34.2%7.6%Unlock

Analyst Ratings

6 Buy
3 Hold
2 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 17.45
(+6.95% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Buy18.00+10.29%15.00UpgradeJan 21, 2026
JPMorgan
Sell15.00-8.09%-DowngradeOct 22, 2025
Morgan Stanley
Hold18.25+11.83%12.50UpgradeSep 23, 2025
Goldman Sachs
Hold15.00-8.09%16.00DowngradeMay 30, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.12%
Dividend Yield
10.04%
Industry Median 2.68%
Annualized payout
1.68
Paid unevenly
5-Years Growth
+11.73%
Growth Streak

Earnings

Latest Release
Mar 05, 2026
EPS / Forecast
0.14 / 0.13
Revenue / Forecast
2.06B / 2.01B
EPS Revisions
Last 90 days

FLRY3 Income Statement

People Also Watch

47.77
PETR4
+1.60%
34.27
BBSE3
-1.24%
85.97
VALE3
-1.43%
23.00
BBAS3
-1.71%

FAQ

What Is the FLEURY ON (FLRY3) Stock Price Today?

The FLEURY ON stock price today is 16.32 BRL.

What Stock Exchange Does FLEURY ON Trade On?

FLEURY ON is listed and trades on the B3 Stock Exchange.

What Is the Stock Symbol for FLEURY ON?

The stock symbol for FLEURY ON is "FLRY3."

Does FLEURY ON Pay Dividends? What’s The Current Dividend Yield?

The FLEURY ON dividend yield is 10.27%.

What Is the FLEURY ON Market Cap?

As of today, FLEURY ON market cap is 8.89B BRL.

What Is FLEURY ON's Earnings Per Share (TTM)?

The FLEURY ON EPS (TTM) is 1.12.

When Is the Next FLEURY ON Earnings Date?

FLEURY ON will release its next earnings report on May 07, 2026.

From a Technical Analysis Perspective, Is FLRY3 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has FLEURY ON Stock Split?

FLEURY ON has split 2 times.

How Many Employees Does FLEURY ON Have?

FLEURY ON has 28000 employees.

What is the current trading status of FLEURY ON (FLRY3)?

As of Apr 24, 2026, FLEURY ON (FLRY3) is trading at a price of 16.32 BRL, with a previous close of 16.32 BRL. The stock has fluctuated within a day range of 16.18 BRL to 16.58 BRL, while its 52-week range spans from 12.16 BRL to 18.10 BRL.

What Is FLEURY ON (FLRY3) Price Target According to Analysts?

The average 12-month price target for FLEURY ON is 17.45 BRL, with a high estimate of 19.3 BRL and a low estimate of 14 BRL. 6 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +6.95% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.